Evidence map›Paper›PMID 33233753›Full record

ArticleMolecules (Basel, Switzerland)2020

Purification and Biochemical Characterization of a New Protease Inhibitor from

Aida Karray, Mona Alonazi, Slim Smaoui, Philippe Michaud, Dina Soliman, Abir Ben Bacha

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Isolation and Purification of Protamine from the CulturedMolecules (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Aida KarrayLaboratoire de Biochimie et de Génie Enzymatique des Lipases, ENIS Route de Soukra, Université de Sfax, Sfax 3038, Tunisia.ORCID 0000-0002-1812-2263
Mona AlonaziBiochemistry Department, Science College, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Slim SmaouiLaboratoire de Microorganismes et de Biomolécules du Center de Biotechnology de Sfax, Route Sidi Mansour km 6 B.P. 117, Sfax 3018, Tunisia.ORCID 0000-0002-8839-7377
Philippe MichaudInstitut Pascal, CNRS, SIGMA Clermont, Université Clermont Auvergne, F-63000 Clermont-Ferrand, 63178 Aubière, France.ORCID 0000-0002-6677-4549
Dina SolimanBotany and Microbiology Department, Science College, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.ORCID 0000-0001-6729-4347
Abir Ben BachaBiochemistry Department, Science College, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.ORCID 0000-0001-6372-7483
King Saud University · SAUniversity of Sfax · TNCentre National de la Recherche Scientifique · FRCentre of Biotechnology of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main objective of the current study was the extraction, purification, and biochemical characterization of a protein protease inhibitor from

Indexed as

Anti-Infective AgentsAntineoplastic AgentsChromatography, GelConyzaDrug StabilityElectrophoresis, Polyacrylamide GelHumansHydrogen-Ion ConcentrationMicrobial Sensitivity TestsOxidantsOxidation-ReductionProtease InhibitorsSolventsTemperatureAnti-Infective AgentsAntineoplastic AgentsOxidantsProtease InhibitorsSolventscharacterization antimicrobial effectConyza dioscoridisprotease inhibitorprotein therapeutics

Identifiers

PMID33233753
PMCPMC7699837
OpenAlexW3098389821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.